United Therapeutics Corporation Stock Repurchase Program, Period in Force (Deprecated 2012-01-31)
United Therapeutics Corporation (UTHR) had Stock Repurchase Program, Period in Force (Deprecated 2012-01-31) of 1 Y as of 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramPeriodInForce · last filed 2012-07-26
- 2012-06-30: Stock Repurchase Program, Period in Force (Deprecated 2012-01-31) 1.00 Y.
- 2011-10-31: Stock Repurchase Program, Period in Force (Deprecated 2012-01-31) 2.00 Y.
- 2011-10-30: Stock Repurchase Program, Period in Force (Deprecated 2012-01-31) 2.00 Y.
- 2011-10-03: Stock Repurchase Program, Period in Force (Deprecated 2012-01-31) 2.00 Y.
| Period end | Stock Repurchase Program, Period in Force (Deprecated 2012-01-31) |
|---|---|
| 2012-06-30 | 1.00 Y 10-Q · filed 2012-07-26 |
| 2011-10-31 | 2.00 Y 10-Q · filed 2012-07-26 |
| 2011-10-30 | 2.00 Y 10-Q · filed 2012-04-26 |
| 2011-10-03 | 2.00 Y 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |